Related Experiment Video
Updated: May 2, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury
Shun Sato1,2, Takeshi Kawasaki1, Ryo Hatano3
1Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Abstract:
Acute respiratory distress syndrome (ARDS) is characterized by dysregulated inflammation and increased permeability of lung microvascular cells. CD26/dipeptidyl peptidase-4 (DPP4) is a type II membrane protein that is expressed in several cell types and mediates multiple pleiotropic effects. We previously reported that DPP4 inhibition by sitagliptin attenuates lipopolysaccharide (LPS)-induced lung injury in mice. The current study characterized the functional role of CD26/DPP4 expression in LPS-induced lung injury in mice, isolated alveolar macrophages, and cultured lung endothelial cells. In LPS-induced lung injury, inflammatory responses [bronchoalveolar lavage fluid (BALF) neutrophil numbers and several proinflammatory cytokine levels] were attenuated in Dpp4 knockout (Dpp4 KO) mice. However, multiple assays of alveolar capillary permeability were similar between the Dpp4 KO and wild-type mice. TNF-α and IL-6 production was suppressed in alveolar macrophages isolated from Dpp4 KO mice. In contrast, in cultured mouse lung microvascular endothelial cells (MLMVECs), reduction in CD26/DPP4 expression by siRNA resulted in greater ICAM-1 and IL-6 expression after LPS stimulation. Moreover, the LPS-induced vascular monolayer permeability in vitro was higher in MLMVECs treated with Dpp4 siRNA, suggesting that CD26/DPP4 plays a protective role in endothelial barrier function. In summary, this study demonstrated that genetic deficiency of Dpp4 attenuates inflammatory responses but not permeability in LPS-induced lung injury in mice, potentially through differential functional roles of CD26/DPP4 expression in resident cellular components of the lung. CD26/DPP4 may be a potential therapeutic target for ARDS and warrants further exploration to precisely identify the multiple functional effects of CD26/DPP4 in ARDS pathophysiology.NEW & NOTEWORTHY We aimed to clarify the functional roles of CD26/DPP4 in ARDS pathophysiology using Dpp4-deficient mice and siRNA reduction techniques in cultured lung cells. Our results suggest that CD26/DPP4 expression plays a proinflammatory role in alveolar macrophages while also playing a protective role in the endothelial barrier. Dpp4 genetic deficiency attenuates inflammatory responses but not permeability in LPS-induced lung injury in mice, potentially through differential roles of CD26/DPP4 expression in the resident cellular components of the lung.
Insights
Genetic deficiency of dipeptidyl peptidase-4 (DPP4) reduces inflammation in acute respiratory distress syndrome (ARDS) models but does not affect lung permeability. DPP4 plays dual roles, promoting inflammation in macrophages and protecting endothelial barriers.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Acute respiratory distress syndrome (ARDS) involves lung inflammation and microvascular cell permeability.
- CD26/dipeptidyl peptidase-4 (DPP4) is a cell surface enzyme with diverse biological functions.
- Previous studies indicated DPP4 inhibition may mitigate lung injury.
Purpose of the Study:
- To investigate the specific roles of CD26/DPP4 in lipopolysaccharide (LPS)-induced lung injury.
- To differentiate the functions of CD26/DPP4 in various lung cell types.
Main Methods:
- Utilized Dpp4 knockout (KO) mice and wild-type littermates.
- Administered LPS to induce lung injury.
- Isolated alveolar macrophages and cultured mouse lung microvascular endothelial cells (MLMVECs).
- Employed small interfering RNA (siRNA) to reduce CD26/DPP4 expression in MLMVECs.
Main Results:
- Dpp4 KO mice showed reduced inflammatory responses (neutrophils, cytokines) but similar lung permeability compared to wild-type mice.
- Alveolar macrophages from Dpp4 KO mice produced less TNF-α and IL-6.
- MLMVECs with reduced CD26/DPP4 expression exhibited increased ICAM-1 and IL-6, and heightened LPS-induced permeability.
Conclusions:
- Genetic deletion of Dpp4 attenuates inflammation but not permeability in LPS-induced lung injury.
- CD26/DPP4 has opposing roles: pro-inflammatory in alveolar macrophages and protective in lung endothelial cells.
- CD26/DPP4 represents a potential therapeutic target for ARDS, requiring further investigation into its complex functions.

